Arkema (OTCMKTS:ARKAY – Get Free Report) released its quarterly earnings data on Thursday. The basic materials company reported $1.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.49 by ($0.09), Zacks reports. Arkema had a net margin of 0.67% and a return on equity of 4.30%.
Arkema Stock Performance
Shares of ARKAY traded up $1.36 during trading hours on Thursday, hitting $66.06. The company had a trading volume of 887 shares, compared to its average volume of 1,887. The business has a fifty day moving average of $64.29 and a 200-day moving average of $66.92. The company has a quick ratio of 1.08, a current ratio of 1.52 and a debt-to-equity ratio of 0.42. The firm has a market cap of $5.02 billion, a price-to-earnings ratio of 227.81 and a beta of 0.87. Arkema has a 12 month low of $56.28 and a 12 month high of $79.36.
Analyst Upgrades and Downgrades
Separately, Barclays upgraded Arkema from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 12th. Six research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.
Check Out Our Latest Report on ARKAY
About Arkema
Arkema is a France-based global specialty materials company that develops and manufactures products used in a wide range of industrial and consumer applications. Its portfolio includes specialty adhesives, high-performance polymers, acrylic materials, coating resins, additives and other chemical solutions designed to improve durability, performance and sustainability.
The company operates through businesses focused on Adhesive Solutions, Advanced Materials and Coating Solutions. Its products serve markets such as construction, automotive, electronics, packaging, renewable energy, consumer goods and industrial manufacturing.
Recommended Stories
- Five stocks we like better than Arkema
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
